MoonLake Immunotherapeutics (MLTX) Stock Price
$50.46 3.6%
to add to portfolio
AI Score
-
Alternative
10 -
Fundamental
6 -
Technical
6
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on MoonLake Immunotherapeutics, AI stock picks, stock alerts and much more.
MLTX AI Stock Analysis
AI stock analysis for MLTX is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like MoonLake Immunotherapeutics (MLTX) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
MoonLake Immunotherapeutics (MLTX) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of MoonLake Immunotherapeutics (MLTX), currently trading at $50.46, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About MLTX
-
MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies.
-
Symbol
MLTX
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
3.2B
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$21.28 1.3% |
7 |
 |
Inovio Pharmaceuticals INO |
$1.44 0.7% |
2 |
 |
Moderna MRNA |
$32.15 1.6% |
3 |
 |
Anavex Life Sciences AVXL |
$11.17 1.7% |
5 |
 |
BridgeBio Pharma BBIO |
$45.62 1.5% |
6 |
News
MLTX Alternative Data
Web Traffic
MoonLake Immunotherapeutics receives an estimated 11334 monthly visitors to moonlaketx.com.
-
Web Traffic
11334
-
Change from Previous Month
175.2%
-
3 Month Change
144.1%
-
YoY Change
144.1%
Twitter Followers
MoonLake Immunotherapeutics has 127 Twitter Followers on its main Twitter (also known as X) account, which is up by 8.5% over the last month.
-
Twitter Followers
127
-
Daily Change
0.8%
-
1 Month Change
8.5%
-
3 Month Change
16.5%
-
YoY Change
16.5%
LinkedIn Followers
7,375 are following MoonLake Immunotherapeutics on LinkedIn, up by 7% over the last month.
-
LinkedIn Followers
7375
-
Daily Change
0.2%
-
1 Month Change
7%
-
3 Month Change
18.9%
Job Postings
MoonLake Immunotherapeutics currenly has an estimated 12 open job postings, up by 20% over the last month.
-
Job Postings
12
-
Daily Change
0%
-
1 Month Change
20%
-
3 Month Change
50%
-
YoY Change
50%
LinkedIn Employees
According to LinkedIn, MoonLake Immunotherapeutics has 129 employees, up by 4.9% over the last month.
-
LinkedIn Employees
129
-
Daily Change
0%
-
1 Month Change
4.9%
-
3 Month Change
12.2%
-
YoY Change
12.2%
Reddit Mentions
MoonLake Immunotherapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
News Mentions
MoonLake Immunotherapeutics was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
50%
-
1 Month Change
0%
-
3 Month Change
0%
MLTX Financials
MLTX Key Metrics
-
Total Revenue
$101.9K
-
Net Income
-$45.6M
-
Earnings per Share
$1.16
-
Free cash flow
-$117B
-
EBITDA
-$48.3M
-
EBITDA Ratio
-474.021
-
Total Assets
$477.9B
MLTX 2-year Revenue & Income
MLTX 2-year Free Cash Flow
MLTX Technicals
MLTX SMA
MLTX RSI
FAQ
What's the current price of MoonLake Immunotherapeutics (MLTX) Stock?
The price of an MoonLake Immunotherapeutics (MLTX) share is $50.46.
What's the market cap of MoonLake Immunotherapeutics?
The current market cap of MoonLake Immunotherapeutics is 3.2B.
Should I buy or sell MLTX?
Multiple alternative data signals suggest that MoonLake Immunotherapeutics stock could offer a buying opportunity at its current level, with a reasonable expectation for positive performance in the mid term.
Is MoonLake Immunotherapeutics a good investment?
Based on an in-depth analysis that encompasses fundamentals, technical analysis, and alternative data insights, it appears to be a favorable time to consider investing in MoonLake Immunotherapeutics stock. The bullish indicators suggest that MoonLake Immunotherapeutics' growth prospects and market position may lead to a positive performance in the foreseeable future.
Is now a good time to buy MoonLake Immunotherapeutics (MLTX) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it could be a favorable time to consider buying MoonLake Immunotherapeutics stock, given the bullish outlook.
What are some stocks similar to MoonLake Immunotherapeutics (MLTX) that investors often compare it to?
MoonLake Immunotherapeutics (MLTX) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for MoonLake Immunotherapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast MoonLake Immunotherapeutics' stock price to be around $57.04 in 2026. Starting from the current price of $50.46, this represents a 13% change in price, indicating a bullish outlook for the stock.
How to buy MoonLake Immunotherapeutics (MLTX) Stock?
MoonLake Immunotherapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy MoonLake Immunotherapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.